MCM
ALBO

MAI Capital Management’s Albireo Pharma Inc ALBO Stock Holding History

MAI Capital Management’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-265,364
Closed -$5.73M – 1109
2022
Q4 		$5.73M Sell
265,364
-141,469
-35% -$2.99M 0.1% 171
2022
Q3 		$7.88M Buy
406,833
+170,686
+72% +$3.53M 0.15% 134
2022
Q2 		$4.69M Buy
236,147
+37,496
+19% +$989K 0.09% 171
2022
Q1 		$5.93M Buy
198,651
+59,100
+42% +$1.73M 0.1% 157
2021
Q4 		$3.25M Buy
139,551
+128,321
+1,143% +$3.41M 0.05% 207
2021
Q3 		$350K Sell
11,230
-1,400
-11% -$43.3K 0.01% 587
2021
Q2 		$444K Sell
12,630
-8,088
-39% -$263K 0.01% 515
2021
Q1 		$730K Sell
20,718
-1,102
-5% -$40.7K 0.02% 402
2020
Q4 		$818K Buy
21,820
+5,584
+34% +$203K 0.02% 363
2020
Q3 		$542K Sell
16,236
-444
-3% -$12.9K 0.02% 385
2020
Q2 		$442K Buy
16,680
+5,100
+44% +$120K 0.01% 411
2020
Q1 		$190K Sell
11,580
-850
-7% -$18.7K 0.01% 495
2019
Q4 		$316K Buy
+12,430
New +$249K 0.01% 455

Other funds holding ALBO

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

MAI Capital Management's ALBO Position: Q1 2023 in Review

MAI Capital Management sold out of Albireo Pharma Inc (ALBO) in Q1 2023, closing a stake of 265,364 shares — an estimated $5.73M sold.

MAI Capital Management first reported a position in ALBO in Q4 2019 and held it in 13 quarters. The position peaked at $7.88M in Q3 2022. 3 funds tracked by Wall St. Rank hold ALBO as of Q1 2023.

  • MAI Capital Management reported no remaining Albireo Pharma Inc position as of Q1 2023 after selling out during the quarter.
  • MAI Capital Management sold 265,364 Albireo Pharma Inc shares in Q1 2023, an estimated $5.73M.
  • MAI Capital Management first reported a position in Albireo Pharma Inc in Q4 2019 and held it in 13 quarters.
  • MAI Capital Management's Albireo Pharma Inc position peaked at $7.88M in Q3 2022.
  • 3 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q1 2023.

Based on MAI Capital Management's 13F filing for Q1 2023, filed 10 May 2023.